MedPath
NMPA Approval

Dobutamine Hydrochloride Injection

国药准字H20244072

June 18, 2024

Drug Information

盐酸多巴酚丁胺注射液

注射剂

40ml:500mg(按C₁₈H₂₃NO₃计)

化学药品

June 18, 2024

Company Information

Applicant Company

沈阳市浑南新区高科路15号

Manufacturing Company

沈阳高新区浑南产业区高科路15号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸多巴酚丁胺注射液 - NMPA 批准文号 | MedPath